-SEC Filing
PhaseBio Pharma Highlights Publication Of Interim Results From Pivotal REVERSE-IT Phase 3 Trial Of Bentracimab In New England Journal Of Medicine Evidence
Results previously presented in a Late-Breaking Science Session at the American Heart Association’s 2021 Scientific Sessions
Global Phase 3 trial of bentracimab achieved both primary reversal endpoint and